GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Interest Coverage

TrivarX (TrivarX) Interest Coverage : 0 (At Loss) (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is TrivarX Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. TrivarX's Operating Income for the six months ended in Dec. 2023 was $-0.73 Mil. TrivarX's Interest Expense for the six months ended in Dec. 2023 was $-0.01 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for TrivarX's Interest Coverage or its related term are showing as below:


MDBIF's Interest Coverage is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 8.99
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


TrivarX Interest Coverage Historical Data

The historical data trend for TrivarX's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

TrivarX Interest Coverage Chart

TrivarX Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

TrivarX Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of TrivarX's Interest Coverage

For the Health Information Services subindustry, TrivarX's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TrivarX's Interest Coverage Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's Interest Coverage distribution charts can be found below:

* The bar in red indicates where TrivarX's Interest Coverage falls into.



TrivarX Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TrivarX's Interest Coverage for the fiscal year that ended in Jun. 2023 is calculated as

Here, for the fiscal year that ended in Jun. 2023, TrivarX's Interest Expense was $-0.01 Mil. Its Operating Income was $-1.80 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

TrivarX did not have earnings to cover the interest expense.

TrivarX's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the six months ended in Dec. 2023, TrivarX's Interest Expense was $-0.01 Mil. Its Operating Income was $-0.73 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

TrivarX did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


TrivarX  (OTCPK:MDBIF) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


TrivarX Interest Coverage Related Terms

Thank you for viewing the detailed overview of TrivarX's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX (TrivarX) Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd Formerly Medibio Ltd is a medical technology company. The principal activity of the company is conducting clinical research, product development, and early-stage commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing monitoring, and management of depression and other mental health conditions. It serves both consumer and healthcare provider markets. In addition, the company offers various psychological services to customers in Australia. The company operates in two geographical markets; Australia and the United States. The company has one operating segment, being the research, development, and commercialization of its Software as a Service product.

TrivarX (TrivarX) Headlines

From GuruFocus

Medibio finalizes acquisition of Vital Conversations

By Marketwired Marketwired 04-12-2018

Medibio Receives CE Certification

By Marketwired Marketwired 05-03-2018

Medibio Granted CE Mark Approval for MEBsleep

By PRNewswire PRNewswire 01-19-2021

Medibio Releases Corporate Health Product, ilumen™

By Marketwired Marketwired 10-03-2018

Medibio Submits FDA De Novo Application

By Marketwired Marketwired 07-16-2018

Peer-reviewed Neurology Publication on Medibio Science

By Marketwired Marketwired 06-27-2018

Medibio Market Update

By Marketwired Marketwired 11-02-2018

Departure of Managing Director & Chief Executive Officer

By Marketwired Marketwired 08-29-2018